| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/25/2001 | CA2406403A1 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof |
| 10/25/2001 | CA2406390A1 Cloning, overexpression and therapeutic uses of bioactive histidine ammonia lyase |
| 10/25/2001 | CA2406213A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 10/25/2001 | CA2406196A1 Therapeutic uses for mesenchymal stromal cells |
| 10/25/2001 | CA2406192A1 Therapeutic compounds and methods for formulating v3, a versican isoform |
| 10/25/2001 | CA2406180A1 Viruses comprising mutant ion channel protein |
| 10/25/2001 | CA2405768A1 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same |
| 10/25/2001 | CA2405709A1 Albumin fusion proteins |
| 10/25/2001 | CA2405701A1 Albumin fusion proteins |
| 10/25/2001 | CA2405563A1 Albumin fusion proteins |
| 10/25/2001 | CA2405557A1 Albumin fusion proteins |
| 10/25/2001 | CA2405555A1 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 10/25/2001 | CA2405550A1 Albumin fusion proteins |
| 10/25/2001 | CA2405525A1 Albumin fusion proteins |
| 10/25/2001 | CA2405451A1 Molecules associated with human reproduction |
| 10/25/2001 | CA2405247A1 Tuberculosis antigens and methods of use thereof |
| 10/25/2001 | CA2405078A1 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 10/25/2001 | CA2404129A1 Codon optimisation for expression in retrovirus packaging cells |
| 10/25/2001 | CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 10/25/2001 | CA2403508A1 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 10/25/2001 | CA2399940A1 Enhancement of antibody-mediated immune responses |
| 10/25/2001 | CA2370572A1 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 10/24/2001 | EP1148127A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor). Its uses |
| 10/24/2001 | EP1148126A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor) |
| 10/24/2001 | EP1148066A1 Use of CD34 or a polypeptide derived therefrom as cell-surface marker in gene-transfer |
| 10/24/2001 | EP1147209A2 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site |
| 10/24/2001 | EP1147208A2 Compositions and methods for intraductal gene therapy |
| 10/24/2001 | EP1147205A1 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| 10/24/2001 | EP1147202A2 Plasminogen kringle 4 region fragments and methods of use |
| 10/24/2001 | EP1147201A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
| 10/24/2001 | EP1147193A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof |
| 10/24/2001 | EP1147191A1 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 10/24/2001 | EP1147190A1 Her-2/neu fusion proteins |
| 10/24/2001 | EP1147188A1 Internal ribosome entry site (ires), vector containing same and the uses thereof |
| 10/24/2001 | EP1147179A2 Human liver progenitors |
| 10/24/2001 | EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 10/24/2001 | EP1147133A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 10/24/2001 | EP1146909A1 Method of treating cancer by restoration of pp32 function |
| 10/24/2001 | EP1146908A1 Formulations comprising antisense nucleotides to connexins |
| 10/24/2001 | EP1146907A2 Use of cationic lipids to generate anti-tumor immunity |
| 10/24/2001 | EP1146897A1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair |
| 10/24/2001 | EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response |
| 10/24/2001 | EP1146881A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 10/24/2001 | EP1146869A2 Inhibition of stat3 signal transduction for human cancer therapy |
| 10/24/2001 | EP1146861A1 Hydrogel particle formulations |
| 10/24/2001 | EP1146855A1 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
| 10/24/2001 | EP0809698B1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6 |
| 10/24/2001 | CN1319139A Polynucleotide constructs and uses thereof |
| 10/24/2001 | CN1319134A Genes of 1-desoxy-D-xylulose biosynthetic pathway |
| 10/24/2001 | CN1319131A Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC |
| 10/23/2001 | US6307129 Herbicide tolerant plants, plant tissue or plant cells having altered protoporphyrinogen oxidase activity |
| 10/23/2001 | US6307027 Bradykinin B1 receptor antibodies |
| 10/23/2001 | US6307022 Def |
| 10/23/2001 | US6307019 Axin gene and uses thereof |
| 10/23/2001 | US6306993 Method and composition for enhancing transport across biological membranes |
| 10/23/2001 | US6306833 Methods and compositions for inducing tumor-specific cytotoxicity |
| 10/23/2001 | US6306832 Peptide antiestrogen compositions and methods for treating breast cancer |
| 10/23/2001 | US6306831 Transplacental delivery of oligonucleotides |
| 10/23/2001 | US6306830 Administering replication-deficient adenoviral vector comprising nucleic acid sequence encoding adenylate cyclase protein linked to promoter; gene expression and engineering; transgene insertion |
| 10/23/2001 | US6306655 Antisense inhibition of C/EBP alpha expression |
| 10/23/2001 | US6306652 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 10/23/2001 | US6306651 Bone marrow hematopoietic stem cell; for use in prevention of graft versus host disease |
| 10/23/2001 | US6306650 Nucleic acid molecule encoding a β-erythroid krüppel-like factor that binds to a δ-globin promoter |
| 10/23/2001 | US6306648 Amino acid sequences for use as enzyme inhibitors; for use in preventing and treatment of oncogenesis; antitumor agents |
| 10/23/2001 | US6306624 Retinoid metabolizing protein |
| 10/23/2001 | US6306622 cDNA encoding a BMP type II receptor |
| 10/23/2001 | US6306604 EPO primary response gene, EPRG3Spt |
| 10/23/2001 | US6306586 Methods and compositions for the diagnosis and treatment of cataracts |
| 10/23/2001 | US6306388 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 10/23/2001 | US6306387 Antigen delivery system |
| 10/23/2001 | CA1341308C Vaccines against avian herpes viruses |
| 10/23/2001 | CA1341307C Nucleotide sequences of avian herpes viruses |
| 10/20/2001 | CA2304494A1 A novel heteromultimeric ion channel receptor and uses thereof |
| 10/18/2001 | WO2001077389A2 Genes expressed in foam cell differentiation |
| 10/18/2001 | WO2001077378A2 Diagnosis of diseases associated with dna adducts |
| 10/18/2001 | WO2001077377A2 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 10/18/2001 | WO2001077376A2 Diagnosis of diseases associated with metastasis |
| 10/18/2001 | WO2001077375A2 Diagnosis of diseases associated with gene regulation |
| 10/18/2001 | WO2001077358A2 Herpes viruses for immune modulation |
| 10/18/2001 | WO2001077357A2 Chromosomal vectors and uses thereof |
| 10/18/2001 | WO2001077339A1 Human pyruvate dehydrogenese phosphatase |
| 10/18/2001 | WO2001077335A2 Listeria monocytogenes genome, polypeptides and uses |
| 10/18/2001 | WO2001077334A2 Lactococcus lactis genome, polypeptides and uses |
| 10/18/2001 | WO2001077331A1 Human trp-like calcium channel protein-2 (tlcc-2) |
| 10/18/2001 | WO2001077327A1 THE HIGH BONE MASS GENE OF 11q13.3 |
| 10/18/2001 | WO2001077323A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 10/18/2001 | WO2001077322A1 Cryptic-like secreted protein |
| 10/18/2001 | WO2001077295A1 Mutant bank |
| 10/18/2001 | WO2001077294A2 Hpv-specific short-mers |
| 10/18/2001 | WO2001077173A1 Tm4sf receptor polynucleotides, polypeptides, and antibodies |
| 10/18/2001 | WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 10/18/2001 | WO2001077164A2 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 10/18/2001 | WO2001077158A1 Hepatitis b core antigen fusion proteins |
| 10/18/2001 | WO2001077154A2 Methods and compositions for stat-1 conferred resistance to immunotoxicity |
| 10/18/2001 | WO2001077152A2 Mammalian disulfide core protein-4 |
| 10/18/2001 | WO2001077151A2 Fdrg proteins and nucleic acid molecules and uses therefor |
| 10/18/2001 | WO2001077149A2 Regulation of human cyslt2-like gpcr protein |
| 10/18/2001 | WO2001077137A1 Albumin fusion proteins |
| 10/18/2001 | WO2001077136A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia |
| 10/18/2001 | WO2001076641A1 Targeted death of cancer cells |